Video Latest - ecancer

Pembrolizumab plus chemo as firstline therapy for NSCLC

Dr Corey Langer - University of Pennsylvania, Philadelphia, USA

9 Oct 2016

ASCEND-5: Ceritinib for ALK positive NSCLC previously treated with crizotinib

Dr Giorgio Scagliotti - University of Turin, Turin, Italy

9 Oct 2016

KRAS in the clinic and conference

Dr Ana Vivancos - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

9 Oct 2016

Phase I results of a novel FGFR inhibitor

Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland

9 Oct 2016

Firstline pembrolizumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA

9 Oct 2016

Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer

Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France

8 Oct 2016

FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer

Prof John Robertson - University of Nottingham, Nottingham, UK

8 Oct 2016

Ribociclib improves progression-free survival in advanced breast cancer

Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center, Houston, US

8 Oct 2016

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France

8 Oct 2016

A novel biomarker for paediatic tumours

Dr Kathleen Birley - UCL Institute of Child Health, London, UK

5 Oct 2016

ALK mutations in paediatric tumours

Dr Suzanne Turner - Cambridge University, Cambridge, UK

5 Oct 2016

Standards in quality for genomic tests

Dr Christine Vietz - Foundation Medicine, Cambridge, USA

5 Oct 2016

Video